Bevacizumab + Capecitabine as Maintenance Therapy after Initial Bevacizumab + XELOX Treatment in Previously Untreated Patients with Metastatic Colorectal Cancer: Phase III ‘Stop and Go' Study Results - A Turkish Oncology Group Trial

Şuayib Yalçin,Ruchan Uslu,Faysal Dane,Ugur Yilmaz,Nurullah Zengin,Evin Büyükünal,Suleyman Buyukberber,Celalettin Camci,Orhan Sencan,Sadettin Kılıçkap,Fatih Ozdener,Duygu Cevik

Bevacizumab + Capecitabine as Maintenance Therapy after Initial Bevacizumab + XELOX Treatment in Previously Untreated Patients with Metastatic Colorectal Cancer: Phase III ‘Stop and Go' Study Results - A Turkish Oncology Group Trial

2013

Şuayib Yalçin
Ruchan Uslu
Faysal Dane
Ugur Yilmaz
Nurullah Zengin
Evin Büyükünal
Suleyman Buyukberber
Celalettin Camci
Orhan Sencan
Sadettin Kılıçkap
Fatih Ozdener
Duygu Cevik

Objective: It was the aim of this study to evaluate maintenance therapy with bevacizumab + capecitabine following induction with bevacizumab + capecitabine + oxal

Keywords:

Bevacizumab
Capecitabine
Colorectal cancer
Oncology
Maintenance therapy
Medicine
Bevacizumab/capecitabine
Oxaliplatin
Internal medicine
group trial
stop and go

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations